From a Global Perspective

Follow FDA international News on X (formerly known as Twitter)

Occasional thought pieces on international topics from experts across the FDA and interviews with global public health leaders.

• FDA India Office Addresses Herbal and Ayurvedic Products, (August 6, 2024)
• World Health Assembly 2024: FDA's Takeaways (July 10, 2024)
• When We Work Together, Hand in Glove with Our Partners, We Can Overcome Any Barrier: A Conversation with EMA's Emer Cooke (June 4, 2024)
• FDA’s Engagement in Global Tobacco Control and Prevention Efforts, (February 28, 2024)
• The Vital Importance of Working in Partnership with Other Regulators – An Interview with MHRA’s CEO Dr. June Raine, (February 20, 2024)
• Looking Back at the Founding of the FDA Foreign Offices, (November 17, 2023)
• Global Efforts to Address Plastic Pollution: An FDA Perspective, (September 27, 2023) 
• The Global Need for Pregnant and Breastfeeding Women in Clinical Research — the Health of the Child Begins with the Health of the Mother (March 29, 2023)
• The WHO Member State Mechanism: Thoughts on the Present and Future (March 2, 2023)
• FDA’s Top Cop: Adapting to Challenges of Globalization and E-commerce (December 28, 2022)
• "We Haven't Finished the Fight" – Commemorating World AIDS Day (December 1, 2022)
• Australia's Robust Strategy for Regional and Global Medical Product Engagement (September 20, 2022)
• The Inter-American Institute for Cooperation in Agriculture: An Essential FDA Partner (August 23, 2022)
• How A European Data Law is Impacting FDA (August 9, 2022)
• FDA's Efforts to Achieve Global Regulatory Harmonization of Generic Drug Programs (March 28, 2022)
• FDA Proposal to Align its Quality Systems with International Consensus Standard Will Benefit Industry and Other Regulators (February 22, 2022)
• Doing the Needful During India's "Second Wave" (August 10, 2021)
• FDA’s Decade-Long Participation in the U.S.-Canada Regulatory Cooperation Council (April 13, 2021)
• China Office Sees Increase in Use of Misleading Medical Device Registration “Certificates” — Points Way to CDRH Action (March 29, 2021)
• Strengthening Scientific Cooperation Between FDA and the European Food Safety Authority (February 1, 2021)
• Global Considerations and Engagements: How FDA’s Global Work is Advancing Public Health (January 15, 2021)
• The WTO’s Decision on Australia’s Plain Packaging Tobacco Measures Explained (December 16, 2020)
• Bookmark this Site! FDA’s Comprehensive Database on Antiretroviral Drugs for HIV under PEPFAR (December 1, 2020)
• FDA’s New Era of Smarter Food Safety Blueprint: Through a Global Lens (November 12, 2020)
• The Story Behind the Reopening of the Molluscan Shellfish Market (October 7, 2020)
• Why the United States-Mexico-Canada Agreement is Important to FDA (July 1, 2020)
• FDA’s Office of Global Policy and Strategy Unveils Key Five-Year Strategic Plan to Strengthen its International Operations (June 24, 2020)
• OGPS Reaches One-Year-Mark (March 31, 2020)
• The Beauty of the Box (February 13, 2020)
• Report Calls for Next Steps to Strengthen Global Food and Drug Systems (January 30, 2020)
• FDA’s Unwavering Commitment to Our Public Health Mission: Reflections on the 30th Anniversary of a Defining Public Health Moment (January 10, 2020)
• Is it Gorgonzola Cheese? How Food Names Impact U.S. Trade (December 16, 2019)
• Measuring the Impact of the Pharmaceutical Annex to the U.S./EU Mutual Recognition Agreement (December 6, 2019)
• A Conversation with FDA Associate Commissioner Mark Abdoo (November 20, 2019)